Page last updated: 2024-10-30

mecamylamine and Idiopathic Parkinson Disease

mecamylamine has been researched along with Idiopathic Parkinson Disease in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Research Excerpts

ExcerptRelevanceReference
"Pretreatment with nicotine, dose-dependently blocked this toxicity."1.38Protective effects of nicotine against aminochrome-induced toxicity in substantia nigra derived cells: implications for Parkinson's disease. ( Caviedes, P; Cuevas, C; Huenchuguala, S; Muñoz, P; Paris, I; Segura-Aguilar, J; Tizabi, Y; Villa, M, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Muñoz, P1
Huenchuguala, S1
Paris, I1
Cuevas, C1
Villa, M1
Caviedes, P1
Segura-Aguilar, J1
Tizabi, Y1

Other Studies

1 other study available for mecamylamine and Idiopathic Parkinson Disease

ArticleYear
Protective effects of nicotine against aminochrome-induced toxicity in substantia nigra derived cells: implications for Parkinson's disease.
    Neurotoxicity research, 2012, Volume: 22, Issue:2

    Topics: Animals; Cell Line; Dicumarol; Dopaminergic Neurons; Dose-Response Relationship, Drug; Indolequinone

2012